STEM-28. DOT1L EPIGENETICALLY REGULATES GBM BRAIN TUMOR STEM CELLS

The median survival for patients diagnosed with Glioblastoma (GBM) is only 14 months, due to recurrence, despite current treatment options of surgery, radio- and chemo- therapies. Recurrence results from the invasion of GBM cancer cells away from the initial cancerous mass and may be due to brain tu...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Neuro Oncol
Prif Awduron: Bozek, Danielle, Wang, Alice, Hao, Xiaoguang, Johnston, Michael, Luchman, H Artee, Weiss, Samuel
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Oxford University Press 2017
Pynciau:
Abstracts
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692879/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.943
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg